Connection

Daniel Steinberg to Time Factors

Back to Details
This is a "connection" page, showing publications Daniel Steinberg has written about Time Factors.
Daniel Steinberg
Connection Strength
0.464
Time Factors
  1. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud? in patients with stroke or transient ischemic attack. Catheter Cardiovasc Interv. 2015 Jun; 85(7):1262-7.
    View in: PubMed
    Score: 0.069
  2. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
    View in: PubMed
    Score: 0.049
  3. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):491-5.
    View in: PubMed
    Score: 0.045
  4. Impact of in-stent restenosis on death and myocardial infarction. Am J Cardiol. 2007 Oct 01; 100(7):1109-13.
    View in: PubMed
    Score: 0.041
  5. Effects of Percutaneous LVAD Support on Right Ventricular Load and Adaptation. J Cardiovasc Transl Res. 2019 04; 12(2):142-149.
    View in: PubMed
    Score: 0.021
  6. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications. Pharmacotherapy. 2017 Apr; 37(4):393-400.
    View in: PubMed
    Score: 0.020
  7. Functioning Cooley-Cutter aortic valve prosthesis 40 years after implantation. J Thorac Cardiovasc Surg. 2014 Mar; 147(3):e21-2.
    View in: PubMed
    Score: 0.016
  8. Recurrent events after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):541-6.
    View in: PubMed
    Score: 0.015
  9. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):838-45.
    View in: PubMed
    Score: 0.015
  10. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv. 2013 Feb; 81(2):335-9.
    View in: PubMed
    Score: 0.014
  11. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv. 2013 Feb; 81(2):348-55.
    View in: PubMed
    Score: 0.014
  12. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv. 2009 Nov 15; 74(6):889-95.
    View in: PubMed
    Score: 0.012
  13. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Revasc Med. 2009 Jul-Sep; 10(3):156-61.
    View in: PubMed
    Score: 0.012
  14. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):866-70.
    View in: PubMed
    Score: 0.012
  15. Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv. 2009 Apr 01; 73(5):612-7.
    View in: PubMed
    Score: 0.011
  16. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
    View in: PubMed
    Score: 0.011
  17. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009 Mar 15; 103(6):801-5.
    View in: PubMed
    Score: 0.011
  18. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):799-803.
    View in: PubMed
    Score: 0.011
  19. Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Nov 15; 102(10):1318-22.
    View in: PubMed
    Score: 0.011
  20. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008 Sep 01; 102(5):530-4.
    View in: PubMed
    Score: 0.011
  21. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
    View in: PubMed
    Score: 0.010
  22. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome? Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):826-31.
    View in: PubMed
    Score: 0.010
  23. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):167-72.
    View in: PubMed
    Score: 0.010
  24. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007 Jul 01; 70(1):9-14.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.